Ostentus Therapeutics, Inc. — Form D
Ostentus Therapeutics, Inc. of NEWPORT COAST, CA, a company, filed a Form D exempt-offering notice with the SEC on 2024-03-08. The offering totals $9.8M, of which $150K was reported sold. Industry: Other Health Care.
Offering
- Filed: 2024-03-08
- Form: D
- Accession: 0001901024-24-000001
- Industry: Other Health Care
- Exemptions: 06c
- Total offering: $9.8M
- Amount sold: $150K
- Remaining: $9.7M
- Minimum investment: $50K
- Investors: 2
- Date of first sale: 2024-02-24
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-507024
Issuer
- Name: Ostentus Therapeutics, Inc.
- CIK: 0001901024
- Entity type: Corporation
- Jurisdiction: CALIFORNIA
- Incorporated: 2021
- Address: 12 GENTLE BREEZE, NEWPORT COAST, CA, 92657
- Phone: 714-658-6562
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Elisabetta Graff | Director | Newport Coast, CA |
| William Graff | Director | Newport Coast, CA |
| Stuart Weinstein | Director | Newport Coast, CA |
| Elisabetta Graff | Executive Officer | Newport Coast, CA |
| Elisabetta Graff | Promoter | Newport Coast, CA |
| William Graff | Promoter | Newport Coast, CA |
| Stuart Weinstein | Promoter | Newport Coast, CA |
Other filings by this issuer (4)
More